This Highly Rated Biotech Company Just Tumbled 13% On A Public OfferingInvestors Business Daily • 12/02/19
This Biotech With 456% Growth In 2019 Just Gained A Price-Target BoostInvestors Business Daily • 11/29/19
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/26/19
Why It Could Soon Be Time To Take Profits In This Highflying Biotech StockInvestors Business Daily • 11/08/19
This Biotech Stock Hurdled A Genetic Barrier — And Flirted With A BreakoutInvestors Business Daily • 10/18/19
Why This Newly Profitable Biotech Stock Is Flirting With A BreakoutInvestors Business Daily • 08/29/19
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/06/19
Why Arrowhead's Promising Gene Silencing Technology Makes The Stock A Strong BuySeeking Alpha • 07/31/19
Highly Rated Biotech Downgraded After Breaking Out And Running 39%Investors Business Daily • 06/28/19